Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 150

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 150
---
ants are independent
of management.

Additionally, under the Companies Law, an audit committee is required,
among other things, to (i) identify deficiencies in the administration of the company (including by consulting with the internal auditor),
and recommend remedial actions with respect to such deficiencies, (ii) review and approve certain related party transactions, including
determining whether or not such transactions are extraordinary transactions or insignificant transactions, and (iii) adopt procedures
with respect to processing employee complaints in connection with deficiencies in the administration of the company, and the appropriate
means of protection afforded to such employees. In addition, the audit committee is responsible for overseeing the internal control procedures
of the company. Under the Companies Law, the approval of the audit committee is required for specified actions and transactions with office
holders and controlling shareholders. See “ - Approval of Related Party Transactions under Israeli Law.”

Compensation and Nominating Committee

Our compensation and nominating committee, or compensation committee,
consists of Mr. Dan Falk, Mr. Nir Nimrodi and Dr. Oded Shoseyov. Mr. Falk serves as the Chairperson of the committee.

Requirements as to Composition

Following the promulgation of the regulations described above,
we may comply with the requirements of the Companies Law by appointing a compensation committee whose composition complies with the Nasdaq
Listing Rules. Under the Nasdaq Listing Rules, we are required to maintain a compensation committee consisting of at least two members,
each of whom qualifies as an independent director (as defined under the Nasdaq Listing Rules). Each compensation committee member must
furthermore be deemed by our board of directors to meet the enhanced independence requirements for members of the compensation committee
under the Nasdaq Listing Rules, which require that our board of directors consider (among other things) the source of each such committee
member’s compensation in determining whether he or she is independent.

Our board of directors has determined that each of the members
of our compensation committee is considered “independent” under the Nasdaq Listing Rules and meets the enhanced independence
requirements for members of the compensation committee under the Nasdaq Listing Rules and Rule 10C-1 under the Exchange Act.

88

Compensation and Nominating
Committee Role

Our board of directors (following approval by our compensation
committee) has adopted a compensation and nominating committee charter setting forth the required composition, meeting procedures and
other matters related to the terms of operation of the committee. The charter also describes the responsibilities of the compensation
committee consistent